Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
US ˙ NYSE ˙ US8816242098

SecurityTEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
InstitutionDAVENPORT & Co LLC
Latest Disclosed Ownership124,086 shares
Latest Disclosed Value $ 3,737,470
DAVENPORT & Co LLC ownership in TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)

On April 15, 2026 - DAVENPORT & Co LLC filed a 13F-HR form disclosing ownership of 124,086 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) (US:TEVA) valued at $3,737,470 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 12, 2026 disclosing 212,737 shares of Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock). This represents a change in shares of -41.67% during the quarter. The current value of the position is $4,242,500 USD.

DAVENPORT & Co LLC has a history of taking positions in derivatives of the underlying security (TEVA) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock) Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-15 2026-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 124,086 -88,651 -41.67 3,737 -43.71 0.0203
2026-01-12 2025-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 212,737 -125,968 -37.19 6,640 -2.95 0.0354
2025-10-15 2025-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 338,705 -24,817 -6.83 6,842 12.29 0.0365
2025-07-22 2025-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 363,522 -107,306 -22.79 6,093 -15.81 0.0332
2025-04-28 2025-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 470,828 89,340 23.42 7,237 -13.93 0.0420
2025-01-24 2024-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 381,488 13,811 3.76 8,408 26.90 0.0475
2024-10-24 2024-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 367,677 -4,981 -1.34 6,626 9.41 0.0376
2024-08-06 2024-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 372,658 30,991 9.07 6,056 25.62 0.0366
2024-05-03 2024-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 341,667 341,667 4,821 0.0296
2023-01-20 2022-12-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 0 -14,408 -100.00 0 -100.00
2022-10-11 2022-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 14,408 14,408 116 0.0010
2022-02-10 2021-12-31 13F TEVA SPONSORED ADS 881624209 0 -11,972 -100.00 0 -100.00
2021-10-14 2021-09-30 13F TEVA SPONSORED ADS 881624209 11,972 -720 -5.67 117 -7.14 0.0008
2021-07-28 2021-06-30 13F/A-2 TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 12,692 0 0.00 126 -13.70 0.0010
2021-04-28 2021-03-31 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 12,692 2,205 21.03 146 44.55 0.0014
2021-01-13 2020-12-31 13F TEVA LTD SPONSORED ADS 881624209 10,487 -2,700 -20.47 101 -15.13 0.0010
2020-10-15 2020-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 13,187 -1,900 -12.59 119 -36.02 0.0013
2020-07-28 2020-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS 881624209 15,087 3,087 25.73 186 72.22 0.0023
2020-05-05 2020-03-31 13F TEVA LTD ADR 881624209 12,000 -500 -4.00 108 -12.20 0.0016
2020-01-22 2019-12-31 13F TEVA ADS 881624209 12,500 12,500 4.17 123 13.89 0.0013
2018-01-17 2017-12-31 13F TEVA ADR 881624209 0 -11,536 -100.00 0 -100.00
2017-10-12 2017-09-30 13F TEVA ADR 881624209 11,536 -14,270 -55.30 203 -76.31 0.0026
2017-07-18 2017-06-30 13F/A-1 TEVA ADR 881624209 25,806 -157 -0.60 857 -8.93 0.0113
2017-07-10 2017-06-30 13F TEVA ADR 881624209 25,713 932
2017-04-11 2017-03-31 13F TEVA ADR 881624209 25,963 63 0.24 941 9.80 0.0134
2017-01-05 2016-12-31 13F TEVA ADR 881624209 25,900 -6,593 -20.29 1 -100.00 0.0135
2016-10-19 2016-09-30 13F TEVA ADR 881624209 32,493 -666 -2.01 1,495 -10.21 0.0220
2016-07-12 2016-06-30 13F TEVA ADR 881624209 33,159 -2,697 -7.52 1,666 -13.19 0.0254
2016-04-25 2016-03-31 13F TEVA ADR 881624209 35,856 -673,107 -94.94 1,919 -95.88 0.0301
2016-01-20 2015-12-31 13F TEVA ADR 881624209 708,963 12,867 1.85 46,536 18.41 0.7528
2015-10-23 2015-09-30 13F TEVA ADR 881624209 696,096 686 0.10 39,302 -4.37 0.6605
2015-08-12 2015-06-30 13F TEVA PHARMACEUTICAL ADR 881624209 695,410 8,122 1.18 41,099 -4.02 0.6371
2015-04-24 2015-03-31 13F TEVA PHARMACEUTICAL INDS ADR 881624209 687,288 687,288 -1.17 42,818 4.19 0.6580
2015-02-04 2014-12-31 13F TEVA PHARMACEUTICAL INDS ADR 881624209 0 -680,109 -100.00 0 -100.00
2014-10-10 2014-09-30 13F TEVA PHARMACEUTICAL INDS ADR 881624209 680,109 6,914 1.03 36,556 3.59 0.6381
2014-07-25 2014-06-30 13F TEVA PHARMACEUTICAL INDS LTD ADR 881624209 673,195 -504,129 -42.82 35,289 -43.28 0.5996
2014-04-21 2014-03-31 13F TEVA PHARMACEUTICAL INDS ADR 881624209 1,177,324 24,022 2.08 62,210 -99.87 1.1274
2014-01-31 2013-12-31 13F TEVA PHARMACEUTICAL INDS ADR 881624209 1,153,302 483,708 72.24 46,224,330 82.72 0.8635
2013-11-05 2013-09-30 13F/A-1 TEVA PHARMACEUTICAL INDS ADR 881624209 669,594 623,758 1,360.85 25,297,271 1,307.92 0.5218
2013-11-01 2013-09-30 13F TEVA PHARMACEUTICAL INDS ADR 881624209 45,836 1,796,784
2013-08-12 2013-06-30 13F TEVA PHARMACEUTICAL INDS ADR 881624209 45,836 45,836 1,796,784 0.0396
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2021-10-14 2021-09-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-07-21 2021-06-30 13F TEVA PHARMACEUTICAL INDS SPONSORED ADS Put 12,692 126 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.